Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...
Hundreds of people are preparing to walk Bonnet Springs Park on Saturday to raise awareness for Alzheimer's disease, its care and research. Polk County's Walk to End Alzheimer's will take place ...
Please log in, or sign up for a new account and purchase a subscription to continue reading. BEST VALUE! Like never before, the Daily News delivers real value every ...
Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...